Cara Therapeutics, Inc. (CARA) financial statements (2021 and earlier)

Company profile

Business Address 4 STAMFORD PLAZA
STAMFORD, CT 06902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:251218183935810753
Cash and cash equivalents3218159121553
Short-term investments149137146834692 
Other undisclosed cash, cash equivalents, and short-term investments716321  (0) 
Restricted cash and investments  0 1  
Receivables2221100
Prepaid expense12952220
Other undisclosed current assets(71)(63)(21)000 
Total current assets:195166168956110953
Noncurrent Assets
Operating lease, right-of-use asset43
Property, plant and equipment1111212
Long-term investments and receivables716321    
Long-term investments716321    
Restricted cash and investments0001111
Total noncurrent assets:7667232223
TOTAL ASSETS:271233191976411156
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:17201491252
Accounts payable5944521
Accrued liabilities1110110
Employee-related liabilities5322211
Other undisclosed accounts payable and accrued liabilities6762421
Deferred revenue 22
Debt 1     
Deferred revenue and credits   1
Contract with customer, liability27
Other undisclosed current liabilities2      
Total current liabilities:18434091253
Noncurrent Liabilities
Long-term debt and lease obligation43     
Operating lease, liability43
Liabilities, other than long-term debt  172213
Deferred revenue and credits2213
Accounts payable and accrued liabilities      0
Contract with customer, liability15
Deferred rent credit  2
Total noncurrent liabilities:73172213
Total liabilities:264657101367
Stockholders' equity
Stockholders' equity attributable to parent249187134875110552
Common stock0000000
Additional paid in capital641587428307213210132
Accumulated other comprehensive income (loss)00(0)(0)0(0) 
Accumulated deficit(392)(401)(294)(220)(162)(105)(80)
Total stockholders' equity:249187134875110552
Other undisclosed liabilities and equity(4)      
TOTAL LIABILITIES AND EQUITY:271233191976411158

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:13520131043
Operating expenses(130)(132)(91)(60)(58)(29)(21)
Operating income (loss):5(112)(77)(59)(58)(25)(18)
Nonoperating income
(Other Nonoperating income)
243110 
Income (loss) from continuing operations before equity method investments, income taxes:8(107)(74)(58)(58)(25)(18)
Other undisclosed income from continuing operations before income taxes      0
Income (loss) from continuing operations before income taxes:8(107)(74)(58)(58)(25)(18)
Income tax benefit1100000
Net income (loss) available to common stockholders, diluted:8(106)(74)(58)(57)(25)(18)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):8(106)(74)(58)(57)(25)(18)
Other comprehensive income (loss)(0)0(0)(0)0(0) 
Comprehensive income (loss), net of tax, attributable to parent:8(106)(74)(58)(57)(25)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: